TY - JOUR
T1 - Differential mitochondrial protein interaction profile between human translocator protein and its A147T polymorphism variant
AU - Asih, Prita R.
AU - Poljak, Anne
AU - Kassiou, Michael
AU - Ke, Yazi D.
AU - Ittner, Lars M.
PY - 2022/5/6
Y1 - 2022/5/6
N2 - The translocator protein (TSPO) has been implicated in mitochondrial transmembrane cholesterol transport, brain inflammation, and other mitochondrial functions. It is upregulated in glial cells during neuroinflammation in Alzheimer’s disease. High affinity TSPO imaging radioligands are utilized to visualize neuroinflammation. However, this is hampered by the common A147T polymorphism which compromises ligand binding. Furthermore, this polymorphism has been linked to increased risk of neuropsychiatric disorders, and possibly reduces TSPO protein stability. Here, we used immunoprecipitation coupled to mass-spectrometry (IP-MS) to establish a mitochondrial protein binding profile of wild-type (WT) TSPO and the A147T polymorphism variant. Using mitochondria from human glial cells expressing either WT or A147T TSPO, we identified 30 WT TSPO binding partners, yet only 23 for A147T TSPO. Confirming that A147T polymorphism of the TSPO might confer loss of function, we found that one of the identified interactors of WT TSPO, 14-3-3 theta (YWHAQ), a protein involved in regulating mitochondrial membrane proteins, interacts much less with A147T TSPO. Our data presents a network of mitochondrial interactions of TSPO and its A147T polymorphism variant in human glial cells and indicate functional relevance of A147T in mitochondrial protein networks.
AB - The translocator protein (TSPO) has been implicated in mitochondrial transmembrane cholesterol transport, brain inflammation, and other mitochondrial functions. It is upregulated in glial cells during neuroinflammation in Alzheimer’s disease. High affinity TSPO imaging radioligands are utilized to visualize neuroinflammation. However, this is hampered by the common A147T polymorphism which compromises ligand binding. Furthermore, this polymorphism has been linked to increased risk of neuropsychiatric disorders, and possibly reduces TSPO protein stability. Here, we used immunoprecipitation coupled to mass-spectrometry (IP-MS) to establish a mitochondrial protein binding profile of wild-type (WT) TSPO and the A147T polymorphism variant. Using mitochondria from human glial cells expressing either WT or A147T TSPO, we identified 30 WT TSPO binding partners, yet only 23 for A147T TSPO. Confirming that A147T polymorphism of the TSPO might confer loss of function, we found that one of the identified interactors of WT TSPO, 14-3-3 theta (YWHAQ), a protein involved in regulating mitochondrial membrane proteins, interacts much less with A147T TSPO. Our data presents a network of mitochondrial interactions of TSPO and its A147T polymorphism variant in human glial cells and indicate functional relevance of A147T in mitochondrial protein networks.
KW - Proteins
KW - Translocator protein (TSPO)
KW - mitochondrial transmembrane cholesterol transport
KW - A147T polymorphism variant
UR - http://www.scopus.com/inward/record.url?scp=85129732595&partnerID=8YFLogxK
UR - http://purl.org/au-research/grants/NHMRC/1136241
UR - http://purl.org/au-research/grants/NHMRC/1132524
UR - http://purl.org/au-research/grants/NHMRC/2001572
UR - http://purl.org/au-research/grants/ARC/DP210101957
U2 - 10.1371/journal.pone.0254296
DO - 10.1371/journal.pone.0254296
M3 - Article
C2 - 35522669
AN - SCOPUS:85129732595
SN - 1932-6203
VL - 17
JO - PLoS One
JF - PLoS One
IS - 5
M1 - e0254296
ER -